Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M, Tsuchiya T, Fukushima Y, Hasegawa T, Hori M, Kitagawa M, Gocho T, Mafune S, Ikeuchi Y, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Matsumoto Y, Sakata KI. Someya M, et al. Among authors: ikeuchi y. Med Mol Morphol. 2021 Sep;54(3):245-252. doi: 10.1007/s00795-021-00290-w. Epub 2021 May 8. Med Mol Morphol. 2021. PMID: 33963949
Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy.
Someya M, Fukushima Y, Hasegawa T, Tsuchiya T, Kitagawa M, Gocho T, Mafune S, Ikeuchi Y, Kozuka Y, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Sakata KI. Someya M, et al. Among authors: ikeuchi y. Jpn J Radiol. 2022 May;40(5):458-465. doi: 10.1007/s11604-021-01231-4. Epub 2022 Jan 1. Jpn J Radiol. 2022. PMID: 34973113 Free PMC article. Review.
Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer.
Someya M, Tokita S, Kanaseki T, Kitagawa M, Hasegawa T, Tsuchiya T, Fukushima Y, Gocho T, Kozuka Y, Mafune S, Ikeuchi Y, Takahashi M, Moniwa K, Matsuo K, Hasegawa T, Torigoe T, Sakata KI. Someya M, et al. Among authors: ikeuchi y. Cancer Sci. 2022 Dec;113(12):4394-4400. doi: 10.1111/cas.15566. Epub 2022 Sep 21. Cancer Sci. 2022. PMID: 36069051 Free PMC article.
Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M, Hasegawa T, Tsuchiya T, Kitagawa M, Fukushima Y, Gocho T, Mafune S, Ikeuchi Y, Kozuka Y, Idogawa M, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Sakata KI. Someya M, et al. Among authors: ikeuchi y. Med Mol Morphol. 2023 Mar;56(1):38-45. doi: 10.1007/s00795-022-00338-5. Epub 2022 Nov 11. Med Mol Morphol. 2023. PMID: 36367588
ARID1B controls transcriptional programs of axon projection in an organoid model of the human corpus callosum.
Martins-Costa C, Wiegers A, Pham VA, Sidhaye J, Doleschall B, Novatchkova M, Lendl T, Piber M, Peer A, Möseneder P, Stuempflen M, Chow SYA, Seidl R, Prayer D, Höftberger R, Kasprian G, Ikeuchi Y, Corsini NS, Knoblich JA. Martins-Costa C, et al. Among authors: ikeuchi y. Cell Stem Cell. 2024 May 6:S1934-5909(24)00141-3. doi: 10.1016/j.stem.2024.04.014. Online ahead of print. Cell Stem Cell. 2024. PMID: 38718796 Free article.
278 results